Merck + Co., Inc.

Myrna E Trumbauer

Howard Y Chen

Hui Zheng

Leonardus H T Van Der Ploeg

John W Hess

Catherine D Strader

Leonardus H Van Der Ploeg

Kathryn J Hofmann

Joseph A Borkowski

Robert P Heavens

Gurparlash Singh

David W Smith

Dalip J S Sirinathsinghji

Aurawan Vongs

Transgenic non-human mammals which express in their brains a nucleic acid construct comprising a DNA sequence encoding a human amyloid precursor protein FAD variant where at amino acid position 717 valine is substituted by isoleucine. These transgenic non-human mammals can be assays systems for determining compounds which are effective in modulating production of human amyloid precursor protein in brain and in isolated neuronal cells. Specifically exemplified are transgenic mice whose genome comprises a DNA sequence encoding a human amyloid precursor protein FAD variant where at amino acid position 717 valine is substituted by isoleucine operably linked to a Thy-1 promoter. The mice are shown to produce the APP-FAD variant in their brains by mRNA and protein assays.

Transgenic mouse expressing a familial form of human amyloid precursor protein

Expression of human interleukin-1.beta. in a transgenic animal

A transgenic non-human animal with alterations in a bradykinin B2 receptor gene is prepared by introduction of a gene encoding an altered bradykinin B2 receptor into a host non-human animal.

Bradykinin B2 receptor modified transgenic non-human animals

Growing community of inventors

Yardley, PA, United States of America

Myrna E Trumbauer